BioSyent Inc. (OTCMKTS:BIOYF) Short Interest Update

BioSyent Inc. (OTCMKTS:BIOYF) was the recipient of a significant decline in short interest in February. As of February 15th, there was short interest totalling 1,700 shares, a decline of 56.4% from the January 31st total of 3,900 shares. Based on an average trading volume of 1,600 shares, the days-to-cover ratio is currently 1.1 days.

BioSyent Price Performance

OTCMKTS BIOYF opened at $7.77 on Friday. The company has a fifty day simple moving average of $7.75 and a 200 day simple moving average of $7.89. BioSyent has a 12-month low of $5.93 and a 12-month high of $8.90.

BioSyent Increases Dividend

The firm also recently disclosed a dividend, which will be paid on Friday, March 14th. Stockholders of record on Monday, March 3rd will be issued a dividend of $0.0347 per share. This is a boost from BioSyent’s previous dividend of $0.03. This represents a dividend yield of 1.77%. The ex-dividend date is Friday, February 28th.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.